Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (381-390 of 529) with videos related to

Pageof 53
Sort By:
Chest|October 22, 2017
Survival of Lung Transplant Candidates With COPD: BODE Score ReconsideredRobert M Reed, Howard J Cabral, Mark T Dransfield, et al.
Science (New York, N.Y.)|April 12, 1996
Positional cloning of the Werner's syndrome geneC E Yu, J Oshima, Y H Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2016
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virusLalita Priyamvada, Kendra M Quicke, William H Hudson, et al.
Vaccines|December 23, 2022
Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 VaccinesMarie I Samanovic, Aaron L Oom, Amber R Cornelius, et al.
The Journal of Infectious Diseases|February 2, 2011
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variantRobert B Belshe, Sharon E Frey, Irene Graham, et al.
Genetic Testing|April 1, 2008
Allelic variation and haplotype structure of the dopamine receptor gene DRD2 in nine Indian populationsL V K S Bhaskar, K Thangaraj, C J Mulligan, et al.
AIDS Research and Human Retroviruses|December 18, 2003
T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I allelesAnju Bansal, Steffanie Sabbaj, Bradley H Edwards, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2019
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy VolunteersNadine G Rouphael, Selwyn J Hurwitz, Mari Hart, et al.
Vaccines|February 12, 2020
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara VaccineEvan J Anderson, Lilin Lai, Jens Wrammert, et al.
Science Translational Medicine|December 7, 2021
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individualsMarie I Samanovic, Amber R Cornelius, Sophie L Gray-Gaillard, et al.
Pageof 53

Showing results (381-390 of 529) with videos related to

Sort By:
Pageof 53
Chest|October 22, 2017
Survival of Lung Transplant Candidates With COPD: BODE Score ReconsideredRobert M Reed, Howard J Cabral, Mark T Dransfield, et al.
Science (New York, N.Y.)|April 12, 1996
Positional cloning of the Werner's syndrome geneC E Yu, J Oshima, Y H Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2016
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virusLalita Priyamvada, Kendra M Quicke, William H Hudson, et al.
Vaccines|December 23, 2022
Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 VaccinesMarie I Samanovic, Aaron L Oom, Amber R Cornelius, et al.
The Journal of Infectious Diseases|February 2, 2011
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variantRobert B Belshe, Sharon E Frey, Irene Graham, et al.
Genetic Testing|April 1, 2008
Allelic variation and haplotype structure of the dopamine receptor gene DRD2 in nine Indian populationsL V K S Bhaskar, K Thangaraj, C J Mulligan, et al.
AIDS Research and Human Retroviruses|December 18, 2003
T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I allelesAnju Bansal, Steffanie Sabbaj, Bradley H Edwards, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2019
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy VolunteersNadine G Rouphael, Selwyn J Hurwitz, Mari Hart, et al.
Vaccines|February 12, 2020
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara VaccineEvan J Anderson, Lilin Lai, Jens Wrammert, et al.
Science Translational Medicine|December 7, 2021
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individualsMarie I Samanovic, Amber R Cornelius, Sophie L Gray-Gaillard, et al.
Pageof 53